We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Cardinal Health
CAH
$54.7B
| $14.8M | 0.03% |
283,700
-5,600
| -2% | -$318K |
|
|
ZEN
552
DELISTED
ZENDESK INC
ZEN
| $14.8M | 0.03% |
200,000
+130,000
| +186% | +$12.8M |
|
|
LCAA
553
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $14.8M | 0.03% |
1,500,000
| – | – |
|
|
APGB
554
DELISTED
Apollo Strategic Growth Capital II
APGB
| $14.7M | 0.03% |
1,500,000
| – | – |
|
555
Iron Mountain
IRM
$37.3B
| $14.7M | 0.03% |
302,652
+300
| +0.1% | +$15.8K |
|
|
NVSA
556
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
| $14.7M | 0.03% |
1,500,350
| – | – |
|
557
Seagate
STX
$192B
| $14.7M | 0.03% |
205,800
-4,500
| -2% | -$366K |
|
558
Darden Restaurants
DRI
$23.4B
| $14.7M | 0.03% |
129,904
-3,500
| -3% | -$437K |
|
|
GSEV
559
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
| $14.7M | 0.03% |
1,500,000
| – | – |
|
560
Xylem
XYL
$28.5B
| $14.7M | 0.03% |
187,593
+49,300
| +36% | +$4.07M |
|
561
Reinsurance Group of America
RGA
$15.5B
| $14.7M | 0.03% |
+125,000
| New | +$14.5M |
|
562
Western Digital
WDC
$189B
| $14.6M | 0.03% |
431,479
+48,157
| +13% | +$1.93M |
|
563
AES
AES
$10.5B
| $14.6M | 0.03% |
+695,512
| New | +$15.2M |
|
564
Healthpeak Properties
DOC
$14.9B
| $14.6M | 0.03% |
561,943
-1,200
| -0.2% | -$36.4K |
|
|
OKLO
565
Oklo
OKLO
$7.54B
| $14.5M | 0.03% |
1,500,000
| – | – |
|
566
Constellation Energy
CEG
$95.4B
| $14.5M | 0.03% |
252,777
-388,200
| -61% | -$23.3M |
|
567
J.M. Smucker
SJM
$12.7B
| $14.5M | 0.03% |
112,927
-200
| -0.2% | -$26.7K |
|
|
KCGI
568
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $14.4M | 0.03% |
1,452,605
| – | – |
|
569
Leidos
LDOS
$16.4B
| $14.3M | 0.03% |
142,300
-261,609
| -65% | -$27.1M |
|
570
Zurn Elkay Water Solutions
ZWS
$8.82B
| $14.3M | 0.03% |
+524,000
| New | +$15.9M |
|
571
Bio-Techne
TECH
$11.2B
| $14.2M | 0.03% |
163,600
-400
| -0.2% | -$37.5K |
|
|
SWTX
572
DELISTED
SpringWorks Therapeutics
SWTX
| $14.2M | 0.03% |
575,000
-1,300,666
| -69% | -$47.6M |
|
573
FMC
FMC
$1.32B
| $14M | 0.03% |
131,200
-1,200
| -0.9% | -$147K |
|
574
Paycom
PAYC
$8.17B
| $14M | 0.03% |
50,100
-200
| -0.4% | -$59K |
|
575
Cintas
CTAS
$81.5B
| $14M | 0.03% |
149,992
-218,408
| -59% | -$21.3M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.